Sonic hedgehog pathway activation is induced by acute brain injury and regulated by injury-related inflammation.
The adult mammalian brain responds to injury by activating a program of cell proliferation during which many oligodendrocyte precursors, microglia, and some astrocytes proliferate. Another common response to brain injury is the induction of reactive gliosis, a process whereby dormant astrocytes undergo morphological changes and alter their transcriptional profiles. Although brain injury-induced reactive gliosis is concurrent with the proliferation of surrounding cells, a functional relationship between reactive gliosis and this cell proliferation has not been clearly demonstrated. Here, we show that the mitogen sonic hedgehog (SHH) is produced in reactive astrocytes after injury to the cerebral cortex and participates in regulating the proliferation of Olig2-expressing (Olig2(+)) cells after brain injury. Using a cortical freeze injury to induce reactive gliosis in a Gli-luciferase reporter mouse, we show that the SHH pathway is maximally active 3 d after brain injury and returns to baseline levels by 14 d. SHH expression parallels Gli activation and localizes to glial fibrillary acidic protein-expressing reactive astrocytes. Inhibition of the SHH pathway with cyclopamine blocks the Gli response and significantly reduces both the proliferating and overall number of Olig2(+) cells in the injured cortex. To provide mechanistic insight into SHH pathway activation in astrocytes, we show that proinflammatory stimuli activate SHH-expressing reactive astrocytes, whereas inhibition of inflammation-induced reactive gliosis by macrophage depletion abolishes SHH activation after brain injury and dampens cell proliferation after injury. Our data describes a unique reactive astrocyte-based, SHH-expressing niche formed in response to injury and inflammation that regulates the proliferation of Olig2(+) cells.
Amankulor
Nduka M
NM
Department of Cancer Biology and Genetics and Neurosurgery, Yale University School of Medicine, New Haven, CT 06510, USA.
Hambardzumyan
Dolores
D
Pyonteck
Stephanie M
SM
Becher
Oren J
OJ
Joyce
Johanna A
JA
Holland
Eric C
EC
D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins / Q000096:biosynthesis; D001930:Brain Injuries / Q000378:metabolism* / Q000473:pathology*; D053823:Hedgehog Proteins / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051379:Mice; D008817:Mice, Mutant Strains; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D000076104:Oligodendrocyte Transcription Factor 2; D015398:Signal Transduction / Q000502:physiology*
D051792:Basic Helix-Loop-Helix Proteins; D053823:Hedgehog Proteins; D018836:Inflammation Mediators; D009419:Nerve Tissue Proteins; D000076104:Oligodendrocyte Transcription Factor 2; C512773:Olig2 protein, mouse; C465570:Shh protein, mouse
Nature. 2005 Oct 6;437(7060):894-7
16208373
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7853-8
16682644
Neurochem Int. 2005 Apr;46(5):381-9
15737436
Restor Neurol Neurosci. 2008;26(2-3):197-214
18820411
J Neurosci. 2008 Oct 22;28(43):10983-9
18945906
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18183-8
16330768
Neuroscience. 2004;127(4):813-20
15312894
J Neurosci. 2008 Jul 9;28(28):7231-43
18614693
Development. 2001 Jul;128(13):2545-54
11493571
FASEB J. 2009 Jan;23(1):21-33
18772349
J Neurosci. 2007 Mar 7;27(10):2596-605
17344397
Biol Reprod. 2007 Aug;77(2):226-36
17392501
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD000196
15674869
J Cereb Blood Flow Metab. 2008 Mar;28(3):468-81
17726492
Glia. 2004 May;46(4):380-90
15095368
Science. 1985 Apr 26;228(4698):497-9
3872478
J Neurochem. 2006 Feb;96(3):893-907
16405499
Nature. 1996 Nov 14;384(6605):129-34
8906787
Development. 2001 Feb;128(4):527-40
11171336
Cancer Res. 2008 Apr 1;68(7):2241-9
18381430
Restor Neurol Neurosci. 2007;25(1):65-76
17473396
Stem Cells. 2008 May;26(5):1221-30
18323412
Dev Biol. 2000 Nov 15;227(2):648-60
11071781
Neuron. 1999 Jun;23(2):297-308
10399936
J Immunol. 2004 May 15;172(10):6418-26
15128833
Development. 2005 Jan;132(2):335-44
15604099
Neurotoxicology. 2001 Oct;22(5):607-18
11770882
Lancet Neurol. 2008 Aug;7(8):728-41
18635021
Neuroscience. 2001;102(4):805-18
11182244
Brain Res. 2007 Jan 19;1129(1):43-52
17169340
J Neurosci. 2008 Jul 2;28(27):6904-13
18596165
J Neuropathol Exp Neurol. 2005 May;64(5):404-11
15892298
J Mol Neurosci. 2004;24(2):201-5
15456933
J Neurosci. 2004 Mar 3;24(9):2143-55
14999065
Development. 1997 Apr;124(7):1313-22
9118802
Development. 1998 Sep;125(18):3553-62
9716521
J Neuroinflammation. 2006 Jun 30;3:15
16808851
Nat Rev Neurosci. 2004 Feb;5(2):146-56
14735117
J Neurotrauma. 2000 Oct;17(10):927-38
11063058
J Neurosci Res. 2008 May 1;86(6):1199-208
18058947
J Clin Invest. 2004 May;113(9):1364-74
15124028
Exp Neurol. 2005 Mar;192(1):11-24
15698615
J Neurosci. 1988 Jul;8(7):2485-90
2470873
Nature. 2006 Aug 17;442(7104):823-6
16799564
Neurochem Res. 2004 Nov;29(11):2069-73
15662841
J Clin Invest. 2005 Jan;115(1):56-65
15630444
Ann Neurol. 2008 Oct;64(4):417-27
18991353
J Neurochem. 2004 Jun;89(5):1092-100
15147501
Brain Res. 1998 Jan 12;780(2):294-303
9507169
J Neuropathol Exp Neurol. 2001 Oct;60(10):961-71
11589427
J Neurosci. 2008 Oct 8;28(41):10434-42
18842903
Perspect Dev Neurobiol. 1994;2(3):269-74
7850360
Brain. 2006 Oct;129(Pt 10):2761-72
16825202
Nature. 1984 Mar 15-21;308(5956):274-5
6700730